Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
900966 | Archives of Clinical Neuropsychology | 2007 | 12 Pages |
Abstract
In this article we review studies in which Automated Neuropsychological Assessment Metrics (ANAM) measures were used to screen for impairment in various clinical populations. These clinical groups include patients with multiple sclerosis, systemic lupus erythematosus, Parkinson's disease, Alzheimer's dementia, acquired brain injury, and migraine headache. Data are also presented from a group of outpatient referrals unselected with respect to clinical condition. Findings support the use of ANAM as a screening procedure for identifying the impaired patient.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Robert L. Kane, Tresa Roebuck-Spencer, Paul Short, Michael Kabat, Jeffrey Wilken,